Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies


April 1, 2012
72 Pages - SKU: XGBR3817529
License type:
Croatia Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
Executive Summary BMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the developmentof the country's private sector. It is also likely to bring about an influx of EU funding in modernising thecountry's  |  read more...
$1,295.00
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due tolow pharmaceutical and healthcare expenditure. The government's low commitment to healthcare,combined with political and economic uncertainties, will remain  |  read more...
$1,295.00
Russian Pharma Industry In Details
5/9/2013 | published by: Euroresearch & Consulting
Russian Pharma Industry In Details Purpose of this report was to analyze Russian of pharma. Please pay attention: Benefits of buying the report: The report included large volume  |  read more...
$3,750.00
Central America Pharmaceuticals and Healthcare Report Q3 2013
5/1/2013 | published by: Business Monitor International
BMI View: Commercial incentives for foreign drugmakers to expand in the Central Americanpharmaceutical market are limited by the region's relatively low per capita pharmaceutical spending andmarket growth. However, the heavy reliance on imported medicine in  |  read more...
$1,175.00
Qatar Pharmaceuticals and Healthcare Report Q2 2013
5/1/2013 | published by: Business Monitor International
BMI View: Qatar represents a largely risk-free proposition for multinational drug manufacturers,although the potential returns are modest, on the account of a small overall market size. Additionally,despite the authorities' desire to increase the domestic medicine  |  read more...
$1,175.00
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
BMI View: The risks of investing in Côte d'Ivoire's pharmaceutical and healthcare industry arenumerous. Politically, the country is in a fragile state, with concerns over security commonplace.Economically, Côte d'Ivoire posts a better performance, but there  |  read more...
$1,295.00
Global Packaging Survey 2013–2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Packaging Industry
4/30/2013 | published by: Canadean Ltd
Global Packaging Survey 2013–2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Packaging Industry Product Synopsis “Global Packaging Survey 2013–2014: Market Trends, Buyer Spend and Procurement Strategies in the Global Packaging Industry” is a  |  read more...
$2,000.00
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
4/30/2013 | published by: GlobalData
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry Summary PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry  |  read more...
$2,995.00
Pneumonia Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for pneumonia treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic  |  read more...
$2,000.00
China Pharmaceutical Guidebook Series (4) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medi
5/20/2013 | published by: Access China Management Consulting Ltd.
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of traditional Chinese medicines almost can not been expressed by  |  read more...
$750.00